SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotime-Nasdaq's best kept secret?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
1432 16 0 BTIM
Emcee:  William Nguyen Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
832 I found some data on the annual U.S. hetastarch usage while reading about coaguStephen How-4/12/1998
831 I finally reviewed the medical literature on coagulopathy of hydroxyethyl starcStephen How-4/12/1998
830 There is a pending deal with Nihon in Japan. A letter of intent has been signeJim Roof-4/7/1998
829 Has there been any word on deals in Asia or Europe to market Hextend? It wouldJohn L.-4/7/1998
828 <<Also, keep in mind that the clock starts when FDA "accepts" tAnaxagoras-4/2/1998
827 Care should be exercised in interpreting the changes in PDUFA. My understandinCMason-4/2/1998
826 I don't think Hextend can exceed the hetastarch limit of 1.5 liters/day (20Stephen How-4/2/1998
825 <<I don't think Hextend can exceed the hetastarch limit of 1.5 litersJim Roof-4/2/1998
824 I don't think Hextend can exceed the hetastarch limit of 1.5 liters/day (2Stephen How-4/2/1998
823 If it is true that HExtend can be used in greater quantities (patients have recJim Roof-4/2/1998
822 An estimate of annual U.S. starch-based plasma expander usage based on CanadianStephen How-4/2/1998
821 I agree. I've already taken a beating on Anesta's (NSTA) Actiq and withTodd N. Weisrock-4/1/1998
820 Do you think Abbot has any clout as to how the FDA responds to BTIM? I know theRon Kline-4/1/1998
819 I seem to remember someone posting that ABT said that they planned to ship HextJim Roof-4/1/1998
818 I just happened across a post on the ZONA thread that gives a little additionalAnaxagoras-4/1/1998
817 Baxter trial news concern: While the Baxter and Biotime products differ in thejohn w. toigo-4/1/1998
816 My suspicion would be that this could create a real boondoggle for the FDA if tJim Roof-4/1/1998
815 <i><<Ie., would the FDA expedite simply by virtue of the simplicityAnaxagoras-4/1/1998
814 I would say then that investors are foolish to be expecting fast track approvalJim Roof-4/1/1998
813 <<I refer to Puck on the fast-track approval likelihood.>> Thanks.Anaxagoras-4/1/1998
812 <i>I have no estimate of the sales figures. I would need to know the totaStephen How-4/1/1998
811 Negatively or positively? The two products are miles apart from a technical stJim Roof-4/1/1998
810 <i>I am not too sure how much this</i>(Baxter HemAssit news)<i&gStephen How-4/1/1998
809 I say it is positive news because some short traders were even doubting whetherJim Roof-4/1/1998
808 Why was the NDA filing supposed to be anything other than "neutral" nStephen How-4/1/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News